Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
08 03 2019
Historique:
received: 01 08 2018
accepted: 13 02 2019
entrez: 10 3 2019
pubmed: 10 3 2019
medline: 4 4 2019
Statut: epublish

Résumé

Frontal fibrosing alopecia (FFA) is a recently described inflammatory and scarring type of hair loss affecting almost exclusively women. Despite a dramatic recent increase in incidence the aetiopathogenesis of FFA remains unknown. We undertake genome-wide association studies in females from a UK cohort, comprising 844 cases and 3,760 controls, a Spanish cohort of 172 cases and 385 controls, and perform statistical meta-analysis. We observe genome-wide significant association with FFA at four genomic loci: 2p22.2, 6p21.1, 8q24.22 and 15q2.1. Within the 6p21.1 locus, fine-mapping indicates that the association is driven by the HLA-B*07:02 allele. At 2p22.1, we implicate a putative causal missense variant in CYP1B1, encoding the homonymous xenobiotic- and hormone-processing enzyme. Transcriptomic analysis of affected scalp tissue highlights overrepresentation of transcripts encoding components of innate and adaptive immune response pathways. These findings provide insight into disease pathogenesis and characterise FFA as a genetically predisposed immuno-inflammatory disorder driven by HLA-B*07:02.

Identifiants

pubmed: 30850646
doi: 10.1038/s41467-019-09117-w
pii: 10.1038/s41467-019-09117-w
pmc: PMC6408457
doi:

Substances chimiques

HLA-B*07:02 antigen 0
HLA-B7 Antigen 0
CYP1B1 protein, human EC 1.14.14.1
Cytochrome P-450 CYP1B1 EC 1.14.14.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1150

Subventions

Organisme : Department of Health
ID : CDF-2014-07-037
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S003126/1
Pays : United Kingdom

Références

Br J Dermatol. 2010 May;162(5):1154-5
pubmed: 20128789
J Pathol. 2013 Oct;231(2):236-47
pubmed: 23788005
Cancer Lett. 2015 Jan 28;356(2 Pt A):231-43
pubmed: 24784887
Pharmacol Ther. 2013 Apr;138(1):103-41
pubmed: 23333322
Sci Rep. 2017 Mar 09;7:44005
pubmed: 28276465
Nat Genet. 2015 Mar;47(3):291-5
pubmed: 25642630
Mol Pharmacol. 2005 Feb;67(2):435-43
pubmed: 15486049
Exp Dermatol. 2016 Nov;25(11):847-852
pubmed: 27198858
Nucleic Acids Res. 2018 Jul 2;46(W1):W486-W494
pubmed: 29762782
J Am Acad Dermatol. 2010 Oct;63(4):653-60
pubmed: 20846567
J Am Acad Dermatol. 2014 Nov;71(5):e208-10
pubmed: 25437995
J Cheminform. 2010 Oct 18;2(1):9
pubmed: 20955607
J Am Acad Dermatol. 2014 Apr;70(4):670-678
pubmed: 24508293
Hum Immunol. 2013 Oct;74(10):1333-8
pubmed: 23916976
Nucleic Acids Res. 2003 Jul 1;31(13):3812-4
pubmed: 12824425
J Investig Dermatol Symp Proc. 2003 Oct;8(2):188-94
pubmed: 14582671
Nat Genet. 2014 Jun;46(6):543-550
pubmed: 24816252
Indian J Dermatol Venereol Leprol. 2015 Mar-Apr;81(2):162-5
pubmed: 25751333
Br J Dermatol. 2013 Jan;168(1):220-2
pubmed: 22716508
Metabolism. 2001 Sep;50(9):1001-3
pubmed: 11555828
PLoS Genet. 2014 May 15;10(5):e1004383
pubmed: 24830394
J Biol Chem. 1988 Oct 15;263(29):15146-50
pubmed: 2971663
Bioinformatics. 2017 Feb 1;33(3):447-449
pubmed: 28171615
Br J Dermatol. 2016 Oct;175(4):762-7
pubmed: 26987767
Dermatol Ther. 2018 Nov;31(6):e12656
pubmed: 30264512
Pharmacol Ther. 2017 Oct;178:18-30
pubmed: 28322972
Genet Epidemiol. 2009 Jan;33(1):79-86
pubmed: 18642345
Am J Hum Genet. 2011 Jan 7;88(1):76-82
pubmed: 21167468
Genome Biol. 2010;11(3):R25
pubmed: 20196867
Bioinformatics. 2012 Apr 15;28(8):1114-21
pubmed: 22355083
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
AIDS Res Hum Retroviruses. 2014 May;30(5):468-75
pubmed: 24010680
Eur J Med Chem. 2017 Jul 28;135:296-306
pubmed: 28458135
Naunyn Schmiedebergs Arch Pharmacol. 2004 Jan;369(1):89-104
pubmed: 14574440
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Curr Drug Metab. 2014;15(9):893-914
pubmed: 25658124
Blood. 2003 Nov 1;102(9):3287-94
pubmed: 12869499
Nat Genet. 2012 Dec;44(12):1294-301
pubmed: 23104008
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
J Am Acad Dermatol. 2018 Jan;78(1):e21-e22
pubmed: 29241802
J Invest Dermatol. 2018 Sep;138(9):1911-1916
pubmed: 30057345
PLoS One. 2013 Jun 06;8(6):e64683
pubmed: 23762245
Bioinformatics. 2010 Sep 1;26(17):2190-1
pubmed: 20616382
Mol Cell Biol. 2007 Feb;27(3):1096-111
pubmed: 17101770
Endocrinology. 2003 Aug;144(8):3382-98
pubmed: 12865317
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
J Am Acad Dermatol. 2015 Jul;73(1):e37
pubmed: 26089074
J Cosmet Dermatol. 2015 Mar;14(1):64-9
pubmed: 25614294
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Immunity. 2000 Mar;12(3):273-83
pubmed: 10755614
Arch Dermatol. 1994 Jun;130(6):770-4
pubmed: 8002649
Br J Dermatol. 2008 Nov;159(5):1077-85
pubmed: 18795933

Auteurs

Christos Tziotzios (C)

St. John's Institute of Dermatology, King's College London, London, Guy's Hospital, London, SE1 9RT, UK. christos.tziotzios@kcl.ac.uk.

Christos Petridis (C)

Department of Medical and Molecular Genetics, King's College London, Guy's Hospital, London, SE1 9RT, UK.

Nick Dand (N)

Department of Medical and Molecular Genetics, King's College London, Guy's Hospital, London, SE1 9RT, UK.

Chrysanthi Ainali (C)

St. John's Institute of Dermatology, King's College London, London, Guy's Hospital, London, SE1 9RT, UK.

Jake R Saklatvala (JR)

Department of Medical and Molecular Genetics, King's College London, Guy's Hospital, London, SE1 9RT, UK.

Venu Pullabhatla (V)

UK NIHR GSTFT/KCL Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust, London, SE1 9RT, UK.

Alexandros Onoufriadis (A)

St. John's Institute of Dermatology, King's College London, London, Guy's Hospital, London, SE1 9RT, UK.

Rashida Pramanik (R)

UK NIHR GSTFT/KCL Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust, London, SE1 9RT, UK.

David Baudry (D)

St. John's Institute of Dermatology, King's College London, London, Guy's Hospital, London, SE1 9RT, UK.

Sang Hyuck Lee (SH)

NIHR Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust (SLaM) & Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, Denmark Hill Campus, London, SE5 8EF, UK.

Kristie Wood (K)

UK NIHR GSTFT/KCL Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust, London, SE1 9RT, UK.

Lu Liu (L)

National Diagnostic EB Laboratory, St. Thomas Hospital, London, SE1 7EH, UK.

Seth Seegobin (S)

St. John's Institute of Dermatology, King's College London, London, Guy's Hospital, London, SE1 9RT, UK.

Gregory A Michelotti (GA)

Metabolon, Inc., Morrisville, NC, 27560, USA.

Su M Lwin (SM)

St. John's Institute of Dermatology, King's College London, London, Guy's Hospital, London, SE1 9RT, UK.

Evangelos A A Christou (EAA)

St. John's Institute of Dermatology, King's College London, London, Guy's Hospital, London, SE1 9RT, UK.

Charles J Curtis (CJ)

UK NIHR GSTFT/KCL Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust, London, SE1 9RT, UK.

Emanuele de Rinaldis (E)

UK NIHR GSTFT/KCL Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust, London, SE1 9RT, UK.

Alka Saxena (A)

UK NIHR GSTFT/KCL Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust, London, SE1 9RT, UK.

Susan Holmes (S)

Alan Lyell Centre for Dermatology, Queen Elizabeth University Hospital, Glasgow, G51 4TF, UK.

Matthew Harries (M)

The Dermatology Centre, The University of Manchester, Salford Royal NHS Foundation Trust, Salford, M6 8HD, UK.

Ioulios Palamaras (I)

Department of Dermatology, Barnet General Hospital, Royal Free Foundation Trust, London, EN5 3DJ, UK.

Fiona Cunningham (F)

Alan Lyell Centre for Dermatology, Queen Elizabeth University Hospital, Glasgow, G51 4TF, UK.

Gregory Parkins (G)

Alan Lyell Centre for Dermatology, Queen Elizabeth University Hospital, Glasgow, G51 4TF, UK.

Manjit Kaur (M)

Department of Dermatology, Solihull Hospital, Solihull, B91 2JL, UK.

Paul Farrant (P)

Department of Dermatology, Brighton and Sussex University Hospitals NHS Trust, Brighton, BN2 3EW, UK.

Andrew McDonagh (A)

Department of Dermatology, Royal Hallamshire Hospital, Sheffield, S10 2JF, UK.

Andrew Messenger (A)

Department of Dermatology, Royal Hallamshire Hospital, Sheffield, S10 2JF, UK.

Jennifer Jones (J)

Department of Dermatology, Royal Free Hospital, London, NW3 2QG, UK.

Victoria Jolliffe (V)

Department of Dermatology, Royal London Hospital, Barts Health NHS Trust, London, E1 1BB, UK.

Iaisha Ali (I)

Department of Dermatology, Imperial College Healthcare NHS Trust, London, W12 0HS, UK.

Michael Ardern-Jones (M)

Department of Dermatology, University Hospitals Southampton NHS Foundation Trust, Southampton, SO16 6YD, UK.

Charles Mitchell (C)

Department of Dermatology, Portsmouth Hospitals NHS Trust, Portsmouth, PO6 3LY, UK.

Nigel Burrows (N)

Department of Dermatology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.

Ravinder Atkar (R)

Department of Dermatology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.

Cedric Banfield (C)

Department of Dermatology, Peterborough City Hospital, Peterborough, PE3 9GZ, UK.

Anton Alexandroff (A)

Department of Dermatology, University Hospitals of Leicester, Leicester Royal Infirmary, Leicester, LE3 9QP, UK.

Caroline Champagne (C)

Department of Dermatology, The Churchill Hospital, Oxford, OX3 7LE, UK.

Hywel L Cooper (HL)

Department of Dermatology, Portsmouth Hospitals NHS Trust, Portsmouth, PO6 3LY, UK.

Sergio Vañó-Galván (S)

Trichology Unit, Dermatology Department, Ramon Y Cajal Hospital, University of Alcala, IRYCIS, Madrid, 28034, Spain.

Ana Maria Molina-Ruiz (AM)

Hospital Universitario Fundación Jiménez Díaz, Madrid, 28040, Spain.

Nerea Ormaechea Perez (NO)

Department of Dermatology, Hospital Donostia, San Sebastian, 20014, Spain.

Girish K Patel (GK)

Hywel Dda University Health Board, Cardiff, SA31 3BB, UK.

Abby Macbeth (A)

Department of Dermatology, Norfolk & Norwich University Hospitals NHS Foundation Trust, Norwich, NR4 7UY, UK.

Melanie Page (M)

Department of Dermatology, Norfolk & Norwich University Hospitals NHS Foundation Trust, Norwich, NR4 7UY, UK.

Alyson Bryden (A)

Department of Dermatology, Ninewells Hospital, Dundee, DD1 9SY, UK.

Megan Mowbray (M)

Department of Dermatology, Queen Margaret Hospital, Dunfermline, KY12 0SU, UK.

Shyamal Wahie (S)

Department of Dermatology, County Durham and Darlington NHS Foundation Trust, Darlington, DL3 6HX, UK.

Keith Armstrong (K)

Department of Dermatology, Royal Victoria Hospital, Belfast, BT12 6BA, UK.

Nicola Cooke (N)

Department of Dermatology, Whiteabbey Hospital, Northern Health & Social Care Trust, Co Antrim, BT37 9RH, UK.

Mark Goodfield (M)

Department of Dermatology, Chapel Allerton Hospital, Leeds teaching Hospitals NHS Trust, Leeds, LS7 4SA, UK.

Irene Man (I)

Department of Dermatology, Surrey and Sussex Healthcare NHS Trust, Surrey, RH1 5RH, UK.

David de Berker (D)

Department of Dermatology, University Hospitals Bristol NHS Foundation Trust, Bristol, BS2 8HW, UK.

Giles Dunnill (G)

Department of Dermatology, University Hospitals Bristol NHS Foundation Trust, Bristol, BS2 8HW, UK.

Anita Takwale (A)

Department of Dermatology, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, GL1 3NN, UK.

Archana Rao (A)

Department of Dermatology, Kingston Hospital NHS Foundation Trust, Kingston-upon-Thames, KT2 7QB, UK.

Tee-Wei Siah (TW)

Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK.

Rodney Sinclair (R)

Department of Dermatology, University of Melbourne, Melbourne, VIC 3010, Australia.

Martin S Wade (MS)

The London Skin and Hair Clinic, London, WC1V 7DN, UK.

Ncoza C Dlova (NC)

Department of Dermatology, School of Clinical Medicine, Nelson R Mandela School of Medicine, Durban, 4001, South Africa.

Jane Setterfield (J)

St. John's Institute of Dermatology, King's College London, London, Guy's Hospital, London, SE1 9RT, UK.

Fiona Lewis (F)

St. John's Institute of Dermatology, King's College London, London, Guy's Hospital, London, SE1 9RT, UK.

Kapil Bhargava (K)

St. John's Institute of Dermatology, King's College London, London, Guy's Hospital, London, SE1 9RT, UK.

Niall Kirkpatrick (N)

Craniofacial Surgery Unit, Chelsea & Westminster Hospital, London, SW10 9NH, UK.

Xavier Estivill (X)

Genetics Unit, Dexeus Women's Health, Barcelona, 08028, Spain.

Catherine M Stefanato (CM)

Department of Dermatopathology, St. John's Institute of Dermatology, St. Thomas' Hospital, London, SE1 7EH, UK.

Carsten Flohr (C)

St. John's Institute of Dermatology, King's College London, London, Guy's Hospital, London, SE1 9RT, UK.

Timothy Spector (T)

The Department of Twin Research & Genetic Epidemiology, King's College London, London, SE1 7EH, UK.

Fiona M Watt (FM)

Centre for Stem Cells and Regenerative Medicine, King's College London, Guy's Hospital, London, SE1 9RT, UK.

Catherine H Smith (CH)

St. John's Institute of Dermatology, King's College London, London, Guy's Hospital, London, SE1 9RT, UK.

Jonathan N Barker (JN)

St. John's Institute of Dermatology, King's College London, London, Guy's Hospital, London, SE1 9RT, UK.

David A Fenton (DA)

St. John's Institute of Dermatology, King's College London, London, Guy's Hospital, London, SE1 9RT, UK.

Michael A Simpson (MA)

Department of Medical and Molecular Genetics, King's College London, Guy's Hospital, London, SE1 9RT, UK.

John A McGrath (JA)

St. John's Institute of Dermatology, King's College London, London, Guy's Hospital, London, SE1 9RT, UK. john.mcgrath@kcl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH